Joel Schneider is Deputy Director of the Center for Cancer Research (CCR) and Chief of the NCI’s Chemical Biology Laboratory. He also served as Editor-in-Chief and is now Executive Editor of Peptide Science, the official journal of the American Peptide Society. His research develops injectable hydrogel materials, bioadhesives, and cellular delivery vehicles capable of delivering therapeutics locally to tissue. He is particularly interested in peptide and protein-based hydrogel materials formed by self-assembly mechanisms.